Also known as آسٹیوپوروسس مینجمنٹ
Diabetologist
FCPS (Medicine), FCPS (Endocrinology), FRCP (UK), MRCP (UK), M.B.B.S.
Diabetologist
FCPS (Medicine), FCPS (Endocrinology), FRCP (UK), MRCP (UK), M.B.B.S.
Endocrinologist
M.B.B.S., M.D, Diplomate American Board Endocrinology , Diabetes and Metabolism, Diplomate American Board of Internal Medicine
Endocrinologist
M.B.B.S., M.D, Diplomate American Board Endocrinology , Diabetes and Metabolism, Diplomate American Board of Internal Medicine
Internal Medicine Specialist
M.B.B.S., F.C.P.S., M.R.C.P. (UK)*
Gastroenterologist
MBBS, MD, MACP, FCPS
Gastroenterologist
M.B.B.S., F.C.P.S. (Gastroenterology)
Gastroenterologist
M.B.B.S, F.C.P.S (Gastroenterology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Lifestyle Medicine Physician
MBBS, Fellowship in Integrative Medicine, Diplomate International Board of Lifestyle Medicine
Lifestyle Medicine Physician
MBBS, Fellowship in Integrative Medicine, Diplomate International Board of Lifestyle Medicine
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Endocrinology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures